CA Stock MarketDetailed Quotes
ACOG Alpha Cognition Inc
- 8.050
- 0.0000.00%
15min DelayMarket Closed Nov 14 15:59 ET
50.83MMarket Cap-1569P/E (TTM)
0.000High0.000Low80Volume10.330Open8.050Pre Close0.00Turnover24.75052wk High0.00%Turnover Ratio6.31MShares7.00052wk Low-5.129EPS TTM35.25MFloat Cap62.250Historical HighLossP/E (Static)4.38MShs Float1.500Historical Low-4.971EPS LYR0.00%Amplitude--Dividend TTM-25.97P/B1Lot Size--Div YieldTTM
About Alpha Cognition Inc Company
Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.
Company Profile
SymbolACOG
Company NameAlpha Cognition Inc
Founded2017
MarketCNQ
Employees4
Fiscal Year Ends12-31
Addressc/o 1200 – 750 West Pender Street
CityVancouver
CountryCAN
Zip CodeV6C 2T8
Phone+1 858 344-4375
Company Executives
- Name
- Position
- Salary
- Michael McFadden
- Chief Executive Officer and Director
- --
- Henry Du
- Vice President, Finance and Accounting and Interim Chief Financial Officer
- --
- Lauren D’Angelo
- Chief Commercial Officer and Chief Operating Officer
- --
- Len Mertz
- Chairman of the Board
- --
- Kenneth A. Cawkell, L.L.B.
- Corporate Secretary and Director
- --
- John Havens
- Independent Director
- --
- Rajeev Bakshi
- Independent Director
- --
- Phillip Mertz
- Independent Director
- --
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data